Lean NAFLD: an underrecognized and challenging disorder in medicine.

Lean NAFLD: an underrecognized and challenging disorder in medicine. Rev Endocr Metab Disord. 2021 Jan 03;: Authors: Maier S, Wieland A, Cree-Green M, Nadeau K, Sullivan S, Lanaspa MA, Johnson RJ, Jensen T Abstract Classically, Non-Alcoholic Fatty Liver Disease (NAFLD) has been thought to be driven by excessive weight gain and obesity. The overall greater awareness of this disorder has led to its recognition in patients with normal body mass index (BMI). Ongoing research has helped to better understand potential causes of Lean NAFLD, the risks for more advanced disease, and potential therapies. Here we review the recent literature on prevalence, risk factors, severity of disease, and potential therapeutic interventions. PMID: 33389543 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33389543?dopt=Abstract

Source: ENDOCR REV - January 3, 2021 Category: Endocrinology Authors: Maier S, Wieland A, Cree-Green M, Nadeau K, Sullivan S, Lanaspa MA, Johnson RJ, Jensen T Tags: Rev Endocr Metab Disord Source Type: research